Hospira's labeling is explicit: Store at 2025C before opening
Approved for use in more than 30 countries for treating hepatitis B, hepatitis C, and cancer-related immune support
Ikke for mennesker eller dyr.
The hypothesis here was that in ovo injection with L-Met would positively enhance the redox status (GSH content) of chicks compared to DL-Met and the control, since L-Met could be immediately converted to Cys and then to GSH in the cytoplasm of hepatocytes
Reconstitution requires Bacteriostatic Water containing 0.9% Benzyl Alcohol (or a suitable equivalent)
Important Safety Information Do not use AOD-9604 if you: Have active cancer or malignancy (use only under medical supervision with appropriate monitoring) Are pregnant or breastfeeding (safety data lacking in these populations) Have known allergy to growth hormone fragments or peptide compounds Have severe uncontrolled metabolic or cardiovascular disease without medical supervision Common side effects may include: Injection site reactions (mild redness, swelling, or tenderness), occasional mild headaches during initial use, and transient lightheadedness